98 related articles for article (PubMed ID: 7587729)
1. DNA aneuploidy in acute myeloblastic leukemia is associated with a high expression of lymphoid markers.
Vidriales MB; Orfao A; López-Berges MC; González M; López-Macedo A; Ciudad J; López A; Cañizo MC; Garcia MA; San Miguel JF
Cytometry; 1995 Mar; 22(1):22-5. PubMed ID: 7587729
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of DNA aneuploidy as a tumor marker].
Takamoto S
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2329-37. PubMed ID: 2751314
[TBL] [Abstract][Full Text] [Related]
3. [DNA aneuploidy in children with acute leukemia: I. Incidence and clinical significance within the scope of the BFM studies].
Hiddemann W; Ritter J; Wörmann B; Budde M; Creutzig U; Schellong G; Büchner T; Riehm H
Klin Padiatr; 1985; 197(3):215-20. PubMed ID: 3859703
[TBL] [Abstract][Full Text] [Related]
4. [DNA aneuploidy in children with acute leukemia: II. Correlation with the phenotype of blasts, clinical picture and course of disease].
Ritter J; Hiddemann W; Wörmann B; Büchner T; Schellong G
Klin Padiatr; 1985; 197(3):221-4. PubMed ID: 3892150
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic characteristics of acute leukaemia after myelodysplastic syndromes.
Lima M; Teixeira Mdos A; Morais S; Cunha M; Coutinho J; Pinho L; Ribeiro P; Justiça B
Sangre (Barc); 1995 Feb; 40(1):49-52. PubMed ID: 7716672
[TBL] [Abstract][Full Text] [Related]
6. Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies.
Bueno C; Almeida J; Lucio P; Marco J; Garcia R; de Pablos JM; Parreira A; Ramos F; Ruiz-Cabello F; Suarez-Vilela D; San Miguel JF; Orfao A
Haematologica; 2004 Jan; 89(1):58-69. PubMed ID: 14754607
[TBL] [Abstract][Full Text] [Related]
7. [Flow cytometry in the determination of DNA aneuploidy in patients with acute leukemias].
Shmarov DA; Kuchma IuM; Miterev GIu; Kozinets GI
Ter Arkh; 1996; 68(7):11-4. PubMed ID: 8928064
[TBL] [Abstract][Full Text] [Related]
8. The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements.
Orfao A; Chillón MC; Bortoluci AM; López-Berges MC; García-Sanz R; Gonzalez M; Tabernero MD; García-Marcos MA; Rasillo AI; Hernández-Rivas J; San Miguel JF
Haematologica; 1999 May; 84(5):405-12. PubMed ID: 10329918
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
10. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
11. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
[TBL] [Abstract][Full Text] [Related]
12. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
Babusíková O; Glasová M; Koníková E; Kusenda J
Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
15. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
16. Definition of acute biphenotypic leukemia.
Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
[TBL] [Abstract][Full Text] [Related]
17. [Cellular immunophenotypes in 97 adults with acute leukemia].
Piedras J; López-Karpovitch X; Cárdenas MR
Rev Invest Clin; 1997; 49(6):457-64. PubMed ID: 9528305
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
[TBL] [Abstract][Full Text] [Related]
19. Expression of MAC-1 (CD11b) in acute myeloid leukemia (AML) is associated with an unfavorable prognosis.
Graf M; Reif S; Kröll T; Hecht K; Nuessler V; Schmetzer H
Am J Hematol; 2006 Apr; 81(4):227-35. PubMed ID: 16550517
[TBL] [Abstract][Full Text] [Related]
20. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
